Testing the Effect of Press Guides on Health Journalists

NCT ID: NCT00938938

Last Updated: 2010-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-06-30

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the effect of adding a "press guide" to standard materials that journalists routinely receive regarding research published in medical journals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The news media has a powerful influence on public perceptions about health and health care; and much of what people -- including many physicians -- know and believe about medicine comes from the print and broadcast media. Several studies, however, have raised questions about how well the press covers medical issues, pointing out errors and omissions in coverage and misleading presentations of statistics. The goal is to help train journalists to better understand and cover medical research, and to help improve communication between journalists and medical journals.

Journalists traditionally write newspaper articles about medical research using information from press releases and the medical journal article's abstract or full text. The objective is to test whether the addition of a 'press guide' (a one-page summary of the study findings) in addition to these other materials improves comprehension of facts about the study article and the overall judgment of the newsworthiness of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medical Reporting

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Press guide plus press release

Participants in the intervention group will receive a press guide (a one-page summary of study findings written by the investigators) in addition to the journal's full narrative press release for the selected article, a copy of the article's abstract, and a link to the full text of the journal article.

Group Type EXPERIMENTAL

Press Guide

Intervention Type OTHER

The press guide is a 1-page summary of the study findings, written by the investigators.

Press release only

Participants in the control group will receive the journal's full narrative press release for the selected article, a copy of the article's abstract, and a link to the full text of the journal article.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Press Guide

The press guide is a 1-page summary of the study findings, written by the investigators.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All journalists attending the 2009 NIH/Dartmouth/VA Medicine in the Media Symposium will be invited to participate in the study.
* The symposium, which is held annually, is open to journalists across the country and from abroad.

Participants who are Health Journalists at the Health Journalism 2010 conference will be invited to participate in the study. This annual conference is being held in Chicago, IL at the Hyatt Regency McCormick Place During April 22, 2010-April 25, 2010.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

White River Junction Veterans Affairs Medical Center

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

White River Junction VAMC

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lisa M. Schwartz, MD, MS

Role: PRINCIPAL_INVESTIGATOR

White River Junction Veterans Affairs Medical Center

References

Explore related publications, articles, or registry entries linked to this study.

Woloshin S, Schwartz LM, Casella SL, Kennedy AT, Larson RJ. Press releases by academic medical centers: not so academic? Ann Intern Med. 2009 May 5;150(9):613-8. doi: 10.7326/0003-4819-150-9-200905050-00007.

Reference Type BACKGROUND
PMID: 19414840 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI R01CA104721

Identifier Type: -

Identifier Source: secondary_id

16782

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.